Askpot
← Company directory

Antibody Characterization & Discovery: Summary

Rapid Novor provides advanced antibody characterization and discovery services powered by mass spectrometry. Their innovative technology enables biotech and pharmaceutical companies to fully harness the potential of antibodies through next-generation protein sequencing.

Service Name

Antibody Characterization & Discovery

Industry

Biotechnology, Life Sciences, Antibody Research, Protein Sequencing

Main Value Proposition

Rapid Novor empowers life science breakthroughs by providing cutting-edge antibody sequencing and characterization services that enhance the understanding of proteins and improve discovery processes.

Description

Rapid Novor provides advanced antibody characterization and discovery services powered by mass spectrometry. Their innovative technology enables biotech and pharmaceutical companies to fully harness the potential of antibodies through next-generation protein sequencing.

Key Features

Monoclonal antibody sequencing from small protein samples with REmAb®; Polyclonal antibody sequencing and discovery service with REpAb®; High-resolution epitope mapping through HDX-MS; Label-free evaluation of antibody-antigen binding with SPR

Use Cases

Antibody engineering for therapeutic development; In vitro diagnostics for disease detection; Biologics drug discovery to create new treatments; Veterinary medicine and research for animal health

Competitive advantages

Proven track record with over 10,000 successful sequencing projects; Innovative technology that reduces risk and increases the probability of technical success; Expertise in high-throughput workflows that speed up antibody discovery

Strengths

The main strengths of Rapid Novor include their patented technology, extensive experience in proteomics, and a strong focus on client success through tailored solutions.

Positioning

Rapid Novor positions itself as a leader in antibody characterization and discovery, leveraging advanced technology to provide unparalleled insights into protein behavior and structure.

Audience

The primary target users are biotech and pharmaceutical companies, researchers in life sciences, and professionals involved in antibody development and characterization.

CTA

Find out how

Tags
  • Antibody Sequencing

  • Protein Characterization

  • Mass Spectrometry

  • Biotech Services

Tagline

Antibody Discovery, Sequencing, and Characterization Services Powered by Mass Spectrometry.

Tone of Voice

Innovative, authoritative, supportive

Differentiation

Rapid Novor's unique integration of bioinformatics, mass spectrometry, and pioneering research allows them to deliver antibody sequencing and discovery results that are not achievable by other companies.

Brand Positioning

The brand is identified as an innovative and reliable partner in the biotech industry, dedicated to advancing antibody research and development through cutting-edge technology.

Founded

2015-04-28

Founders
  • Mingjie Xie